Finizio Robert G 4
4 · TherapeuticsMD, Inc. · Filed Mar 8, 2021
Insider Transaction Report
Form 4
Finizio Robert G
DirectorChief Executive Officer10% Owner
Transactions
- Exercise of In-Money
Common Stock
2021-03-04$0.24/sh+179,000$43,748→ 18,580,964 total - Tax Payment
Common Stock
2021-03-04$1.46/sh−29,964$43,747→ 18,551,000 total - Gift
Common Stock
2021-03-05−350,000→ 18,201,000 total - Gift
Common Stock
2020-02-28−300,000→ 17,901,000 total - Exercise of In-Money
Warrants (right to buy)
2021-03-04−179,000→ 0 totalExercise: $0.24Exp: 2021-03-06→ Common Stock (179,000 underlying)
Holdings
- 2,000,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]On March 4, 2021, the reporting person exercised a warrant to purchase 179,000 shares of issuer common stock for $0.2444 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 29,964 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 149,036 shares.
- [F2]The reported securities are owned by Robert Finizio Revocable Trust. Includes 1,004,941 shares previously reported as indirectly owned by the reporting person's Grantor-Retained Annuity Trust.
- [F3]The warrant vested quarterly in eight equal installments commencing June 30, 2011, becoming fully-vested on March 31, 2013.